Hiran Orgochem has received an approval to invest the GDR proceeds of up to $5 million in wholly-owned subsidiary (WOS) to be set up in Mauritius. The board of directors at its meeting held on May 31, 2013 has approved for the same.
Hiran Orgochem is a leading integrated manufacturer of active pharmaceutical ingredients and formulations. Since its incorporation, the company has focused on Manufacturing the Quinolones group of API's with its principal products comprising Ciprofloxacin, Ofloxacin, Levofloxacin, Enrofloxacin and now provides formulations as well.
